• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻患者与老年患者行玻璃体切除术治疗增生型糖尿病视网膜病变的特征和结局。

Characteristics and outcomes of vitrectomy for proliferative diabetic retinopathy in young versus senior patients.

机构信息

Department of Ophthalmology, Tianjin Medical University General Hospital, No.154 Anshan Road, Tianjin, 300052, China.

Laboratory of Molecular Ophthalmology, Tianjin Medical University, Tianjin, China.

出版信息

BMC Ophthalmol. 2020 Oct 19;20(1):416. doi: 10.1186/s12886-020-01688-3.

DOI:10.1186/s12886-020-01688-3
PMID:33076873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7574415/
Abstract

BACKGROUND

Proliferative diabetic retinopathy (PDR) is one of the most common cause of vision loss in diabetic patients, and the incidence age of PDR patients gradually gets younger. This study aims to compare the characteristics of PDR and outcomes following vitrectomy in young and senior patients.

METHODS

This is a retrospective case series study. Data of 116 eyes of 92 patients who underwent vitrectomy for PDR from February 2012 to February 2017 were reviewed, which were divided into young and senior patient groups. All patients were followed up for 24 months at least.

RESULTS

There were 62.1% of eyes with tractional retinal detachment secondary to PDR in the young patient group, while only 12.1% of eyes in the senior patient group with this surgery indication. (P < 0.001) The best corrected visual acuity increased in 41 eyes (70.7%), stable in 9 eyes (15.5%), and decreased in 8 eyes (13.8%) in young patients at the final follow-up. And it increased in 47 eyes (81.0%), stable in 2 eyes (3.4%), and decreased in 9 eyes (15.5%) in senior patients.(P = 0.085) Postoperative complications mainly included recurrent vitreous hemorrhage (24.1%), retinal detachment (3.4%), neovascular glaucoma (NVG) (27.6%) and nuclear sclerosis (53.4%) in young patients, and it was 19.0, 0.0, 1.7 and 3.4% in senior patients respectively.

CONCLUSION

PDR of young patients is more severe than that of senior patients, and vitrectomy is an effective and safe method for PDR treatment. NVG is a main and severe complication besides nuclear sclerosis in young patients, and the incidence of NVG is higher compared to that in senior patients.

摘要

背景

增生型糖尿病视网膜病变(PDR)是糖尿病患者视力丧失的最常见原因之一,且 PDR 患者的发病年龄逐渐年轻化。本研究旨在比较年轻和老年 PDR 患者行玻璃体切除术的特点和结局。

方法

这是一项回顾性病例系列研究。对 2012 年 2 月至 2017 年 2 月期间因 PDR 接受玻璃体切除术的 92 例患者的 116 只眼进行了回顾性分析,将患者分为年轻患者组和老年患者组。所有患者的随访时间均至少为 24 个月。

结果

年轻患者组因 PDR 导致牵拉性视网膜脱离的眼占 62.1%,而老年患者组中具有该手术适应证的眼仅占 12.1%(P<0.001)。在最终随访时,年轻患者组中 41 只眼(70.7%)的最佳矫正视力提高,9 只眼(15.5%)稳定,8 只眼(13.8%)下降。老年患者组中 47 只眼(81.0%)的最佳矫正视力提高,2 只眼(3.4%)稳定,9 只眼(15.5%)下降(P=0.085)。年轻患者术后主要并发症包括复发性玻璃体积血(24.1%)、视网膜脱离(3.4%)、新生血管性青光眼(NVG)(27.6%)和核性白内障(53.4%),老年患者的发生率分别为 19.0%、0.0%、1.7%和 3.4%。

结论

年轻患者的 PDR 比老年患者更严重,玻璃体切除术是治疗 PDR 的有效且安全的方法。NVG 是年轻患者除核性白内障外的主要且严重的并发症,其发生率高于老年患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4036/7574415/cf761d4c0476/12886_2020_1688_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4036/7574415/d210e5af87c3/12886_2020_1688_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4036/7574415/980409f1a00b/12886_2020_1688_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4036/7574415/cf761d4c0476/12886_2020_1688_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4036/7574415/d210e5af87c3/12886_2020_1688_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4036/7574415/980409f1a00b/12886_2020_1688_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4036/7574415/cf761d4c0476/12886_2020_1688_Fig3_HTML.jpg

相似文献

1
Characteristics and outcomes of vitrectomy for proliferative diabetic retinopathy in young versus senior patients.年轻患者与老年患者行玻璃体切除术治疗增生型糖尿病视网膜病变的特征和结局。
BMC Ophthalmol. 2020 Oct 19;20(1):416. doi: 10.1186/s12886-020-01688-3.
2
Risk Factors of Neovascular Glaucoma After 25-gauge Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study.增生型糖尿病视网膜病变伴玻璃体积血 25G 玻璃体切割术后新生血管性青光眼的危险因素:一项回顾性多中心研究。
Sci Rep. 2019 Oct 16;9(1):14858. doi: 10.1038/s41598-019-51411-6.
3
Vitrectomy for complications of proliferative diabetic retinopathy in young adults: clinical features and surgical outcomes.年轻成人增生性糖尿病视网膜病变并发症的玻璃体切除术:临床特征与手术结果
Graefes Arch Clin Exp Ophthalmol. 2017 May;255(5):863-871. doi: 10.1007/s00417-016-3579-4. Epub 2017 Jan 6.
4
Influencing factors of low vision 2 years after vitrectomy for proliferative diabetic retinopathy: an observational study.增殖型糖尿病性视网膜病变玻璃体切除术后 2 年低视力的影响因素:一项观察性研究。
BMC Ophthalmol. 2023 Jul 10;23(1):309. doi: 10.1186/s12886-023-03071-4.
5
Effect of intravitreal ranibizumab pretreatment on vitrectomy in young patients with proliferative diabetic retinopathy.玻璃体内注射雷珠单抗预处理对年轻增殖性糖尿病视网膜病变患者玻璃体切除术的影响。
Ann Palliat Med. 2020 Jan;9(1):82-89. doi: 10.21037/apm.2020.01.10.
6
Long-term results of vitreous surgery for proliferative diabetic retinopathy.增殖性糖尿病视网膜病变玻璃体手术的长期效果
Doc Ophthalmol. 1994;87(3):223-32. doi: 10.1007/BF01203852.
7
Visual outcomes and complications following one-way air-fluid exchange technique for vitreous hemorrhage post vitrectomy in proliferative diabetic retinopathy patients.增生型糖尿病视网膜病变患者玻璃体切除术后玻璃体积血行单向空气-液体交换术后的视力结果和并发症。
BMC Ophthalmol. 2021 Mar 9;21(1):129. doi: 10.1186/s12886-021-01885-8.
8
[Different outcome among eyes with proliferative diabetic retinopathy indicated for vitrectomy].[拟行玻璃体切除术的增殖性糖尿病视网膜病变患者的不同预后]
Nippon Ganka Gakkai Zasshi. 2006 Dec;110(12):950-60.
9
Outcomes and complications of 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy.25G 经结膜无缝线玻璃体切除术治疗增生性糖尿病视网膜病变的结果和并发症。
Ophthalmologica. 2011;226(2):76-80. doi: 10.1159/000328407. Epub 2011 May 25.
10
Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy.增生型糖尿病视网膜病变玻璃体切割术后玻璃体积血的原因及处理。
Curr Eye Res. 2010 Apr;35(4):308-13. doi: 10.3109/02713680903572491.

引用本文的文献

1
Personalized Management of Patients with Proliferative Diabetic Vitreoretinopathy.增殖性糖尿病性玻璃体视网膜病变患者的个性化管理
Life (Basel). 2024 Aug 9;14(8):993. doi: 10.3390/life14080993.
2
Bilateral vitrectomy in patients with proliferative diabetic retinopathy-characteristics and surgical outcomes.双侧玻璃体切除术治疗增生性糖尿病视网膜病变患者的特征和手术结果。
Graefes Arch Clin Exp Ophthalmol. 2024 Sep;262(9):2833-2844. doi: 10.1007/s00417-024-06462-5. Epub 2024 Apr 5.
3
Functional and structural outcomes and complications after pars plana vitrectomy for severe features of proliferative diabetic retinopathy in type 1 and type 2 diabetes mellitus.

本文引用的文献

1
Intravitreal ranibizumab injection at the end of vitrectomy for diabetic vitreous hemorrhage (Observational Study).糖尿病性玻璃体积血玻璃体切除术后玻璃体内注射雷珠单抗(观察性研究)。
Medicine (Baltimore). 2019 May;98(20):e15735. doi: 10.1097/MD.0000000000015735.
2
Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy.增殖性糖尿病视网膜病变患者玻璃体切除术后新生血管性青光眼的危险因素
Clin Ophthalmol. 2018 Nov 14;12:2323-2329. doi: 10.2147/OPTH.S184959. eCollection 2018.
3
Posterior Vitreous Detachment.
1 型和 2 型糖尿病增殖性糖尿病视网膜病变严重特征的经睫状体平坦部玻璃体切除术的功能和结构结果及并发症。
PLoS One. 2023 Jul 20;18(7):e0288805. doi: 10.1371/journal.pone.0288805. eCollection 2023.
4
Comparison of Clinical Profiles, Demographics, and Surgical Outcomes of 25-Gauge Vitrectomy for Proliferative Diabetic Retinopathy in Young Adults with Type 1 or Type 2 Diabetes.1型或2型糖尿病青年患者增生性糖尿病视网膜病变25G玻璃体切除术的临床特征、人口统计学和手术结果比较
Diabetes Metab Syndr Obes. 2023 Jun 29;16:1967-1975. doi: 10.2147/DMSO.S412157. eCollection 2023.
5
Refining vitrectomy for proliferative diabetic retinopathy.精细化玻璃体切割术治疗增生型糖尿病视网膜病变。
Graefes Arch Clin Exp Ophthalmol. 2023 Dec;261(12):3659-3670. doi: 10.1007/s00417-023-06134-w. Epub 2023 Jun 14.
6
Network meta-analysis of intravitreal conbercept as an adjuvant to vitrectomy for proliferative diabetic retinopathy.网络荟萃分析玻璃体内康柏西普作为辅助治疗增生性糖尿病视网膜病变的玻璃体切除术。
Front Endocrinol (Lausanne). 2023 Feb 22;14:1098165. doi: 10.3389/fendo.2023.1098165. eCollection 2023.
7
Clinical Characteristics and Surgical Outcomes of Complications of Proliferative Diabetic Retinopathy in Young versus Older Patients with Type 2 Diabetes.2型糖尿病年轻与老年患者增殖性糖尿病视网膜病变并发症的临床特征及手术结果
Diabetes Metab Syndr Obes. 2023 Jan 11;16:37-45. doi: 10.2147/DMSO.S382603. eCollection 2023.
8
Outcomes of Pars Plana Vitrectomy with Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy Without Retinal Detachment: A Seven-Year Retrospective Study.不伴有视网膜脱离的增生性糖尿病视网膜病变行玻璃体切割联合全视网膜光凝术的疗效:一项七年回顾性研究
Clin Ophthalmol. 2023 Feb 1;17:471-478. doi: 10.2147/OPTH.S400474. eCollection 2023.
9
Tortuosity of branch retinal artery is more associated with the genesis and progress of diabetic retinopathy.分支视网膜动脉迂曲与糖尿病视网膜病变的发生和进展更相关。
Front Endocrinol (Lausanne). 2022 Oct 6;13:972339. doi: 10.3389/fendo.2022.972339. eCollection 2022.
10
A Paradigm Shift in the Management Approaches of Proliferative Diabetic Retinopathy: Role of Anti-VEGF Therapy.增殖性糖尿病视网膜病变管理方法的范式转变:抗血管内皮生长因子治疗的作用
Clin Ophthalmol. 2022 Sep 8;16:3005-3017. doi: 10.2147/OPTH.S374165. eCollection 2022.
玻璃体后脱离
Ophthalmology. 2018 Sep;125(9):1384-1385. doi: 10.1016/j.ophtha.2018.05.018. Epub 2018 Aug 21.
4
Prevalence and risk factors for diabetic retinopathy in China: a multi-hospital-based cross-sectional study.中国糖尿病视网膜病变的患病率及危险因素:一项基于多医院的横断面研究。
Br J Ophthalmol. 2017 Dec;101(12):1591-1595. doi: 10.1136/bjophthalmol-2017-310316. Epub 2017 Aug 30.
5
Neovascular glaucoma after vitrectomy in patients with proliferative diabetic retinopathy.增殖性糖尿病视网膜病变患者玻璃体切除术后的新生血管性青光眼
Medicine (Baltimore). 2017 Mar;96(10):e6263. doi: 10.1097/MD.0000000000006263.
6
Vitrectomy for complications of proliferative diabetic retinopathy in young adults: clinical features and surgical outcomes.年轻成人增生性糖尿病视网膜病变并发症的玻璃体切除术:临床特征与手术结果
Graefes Arch Clin Exp Ophthalmol. 2017 May;255(5):863-871. doi: 10.1007/s00417-016-3579-4. Epub 2017 Jan 6.
7
Characteristics of cases with postoperative vitreous hemorrhage after 25-gauge vitrectomy for repair of proliferative diabetic retinopathy.25G玻璃体切割术治疗增殖性糖尿病视网膜病变术后玻璃体出血病例的特征
Graefes Arch Clin Exp Ophthalmol. 2017 Apr;255(4):665-671. doi: 10.1007/s00417-016-3522-8. Epub 2016 Oct 21.
8
Age-related cataract and its types in patients with and without type 2 diabetes mellitus: A Hospital-based comparative study.2型糖尿病患者与非2型糖尿病患者的年龄相关性白内障及其类型:一项基于医院的比较研究。
J Pak Med Assoc. 2016 Oct;66(10):1272-1276.
9
Outcomes of 23-Gauge Vitrectomy Combined with Phacoemulsification, Panretinal Photocoagulation, and Trabeculectomy without Use of Anti-VEGF Agents for Neovascular Glaucoma with Vitreous Hemorrhage.23G玻璃体切除术联合超声乳化白内障吸除术、全视网膜光凝和小梁切除术治疗合并玻璃体积血的新生血管性青光眼且不使用抗VEGF药物的疗效
J Ophthalmol. 2016;2016:3097379. doi: 10.1155/2016/3097379. Epub 2016 Jan 17.
10
Neovascular glaucoma: a retrospective review from a tertiary center in China.新生血管性青光眼:来自中国一家三级中心的回顾性研究。
BMC Ophthalmol. 2016 Jan 27;16:14. doi: 10.1186/s12886-016-0190-8.